These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6233994)

  • 101. Evaluating drugs after their approval for clinical use.
    Ray WA; Griffin MR; Avorn J
    N Engl J Med; 1993 Dec; 329(27):2029-32. PubMed ID: 8018139
    [No Abstract]   [Full Text] [Related]  

  • 102. Yellow cards and green forms.
    Inman WH
    Practitioner; 1983 Sep; 227(1383):1443-9. PubMed ID: 6647229
    [No Abstract]   [Full Text] [Related]  

  • 103. Postmarketing surveillance.
    Oleen MA
    Can J Hosp Pharm; 1987 Oct; 40(5):171-2, 179-80. PubMed ID: 10284449
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Postmarketing surveillance for drug safety: surely we can do better.
    Griffin MR; Stein CM; Ray WA
    Clin Pharmacol Ther; 2004 Jun; 75(6):491-4. PubMed ID: 15179403
    [No Abstract]   [Full Text] [Related]  

  • 105. Reducing medication errors and increasing patient safety: case studies in clinical pharmacology.
    Benjamin DM
    J Clin Pharmacol; 2003 Jul; 43(7):768-83. PubMed ID: 12856392
    [TBL] [Abstract][Full Text] [Related]  

  • 106. [Drug surveillance. Monitoring the side-effects of drugs in the post-marketing phase: cimetidine. II].
    Mariani L; Minora T
    Clin Ter; 1984 Apr; 109(2):109-25. PubMed ID: 6234121
    [No Abstract]   [Full Text] [Related]  

  • 107. Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification.
    Mann K; Rothschild JM; Keohane CA; Chu JA; Bates DW
    World J Biol Psychiatry; 2008; 9(1):24-33. PubMed ID: 17853253
    [TBL] [Abstract][Full Text] [Related]  

  • 108. [Adverse reactions to drugs and drug surveillance].
    Laporte JR
    Med Clin (Barc); 1989 Apr; 92(14):536-8. PubMed ID: 2666766
    [No Abstract]   [Full Text] [Related]  

  • 109. Methods in monitoring. A review of techniques of drug surveillance.
    Powell C
    Gerontol Clin (Basel); 1974; 16(1):112-7. PubMed ID: 4604766
    [No Abstract]   [Full Text] [Related]  

  • 110. [Drug surveillance in patients of advanced-age].
    Bol Oficina Sanit Panam; 1984 Apr; 96(4):342-52. PubMed ID: 6233994
    [No Abstract]   [Full Text] [Related]  

  • 111. [Critical study of methods of postmarketing drug surveillance].
    Gut JP; Auriche M; Spriet-Pourra C; Juillet Y
    Therapie; 1985; 40(5):313-9. PubMed ID: 3913048
    [No Abstract]   [Full Text] [Related]  

  • 112. [Pitfalls of polypharmacy, particularly in the elderly].
    Queneau P
    Bull Mem Acad R Med Belg; 2006; 161(6):408-21; discussion 422-4. PubMed ID: 17288274
    [TBL] [Abstract][Full Text] [Related]  

  • 113.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.